Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
Clinical trial NCT03245021 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03245021
- Sponsor
- Dr. Eliza Hawkes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2022-05-11
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.